Search Results 21-30 of 16835 for Linaclotide

  1. In Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the effectiveness and safety of Lubiprostone in pediatric patients, aged ≥ 6 years to < 18 years, diagnosed with ...

  2. Publications - William L. Hasler, M.D. - Mayo Clinic

    ... linaclotide. Gastroenterology 2013 Dec; 145 (6):1196-9. View PubMed; Hasler WL. Geography lessons: scrutinizing state-by-state differences in inpatient ...

  3. Lacosamide (oral route) - Side effects & dosage - Mayo Clinic

    Description. Lacosamide is used to treat partial-onset seizures. It is also used with other medicines to treat primary generalized tonic-clonic seizures.

  4. Niacin and lovastatin (oral route) - Side effects & dosage - Mayo Clinic

    Niacin and lovastatin combination is used together with a proper diet to help lower cholesterol and triglyceride (fat) levels in the blood. This medicine may ...

  5. Clinical trials - Oncology (Medical)

    There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

  6. Collagenase clostridium histolyticum-aaes (subcutaneous route) - Side effects & uses - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  7. Incobotulinumtoxina (intraglandular route, intramuscular route) - Side effects & uses - Mayo Clinic

    Description. IncobotulinumtoxinA is used to treat the abnormal head position and neck pain that result from cervical dystonia (severe muscle spasms of the ...

  8. Normal and Dyssynergic Defecation - Mayo Clinic

    Current use of laxatives (MiraLax, Ex-lax, senna, herbal supplements), linaclotide, lubiprostone, and prucalopride to treat constipation- patients using ...

  9. A Study of the Use of a Squatting Assist Device in Patients with Constipation - Mayo Clinic

    ... linaclotide, lubiprostone, and prucalopride to treat constipation will be eligible if can discontinue the medication at least 3 days (72 hrs.) before the ...

  10. Ciltacabtagene autoleucel (intravenous route) - Side effects & uses - Mayo Clinic

    Ciltacabtagene autoleucel injection is an antineoplastic (cancer) medicine that is made from your own white blood cells, which have been modified to recognize ...